Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker's. "We ...

In January, Amgen laid off about 300 employees as part of organizational changes, which "mainly" impacted the U.S.-based commercial team. "We made these changes to better manage against industry ...

(Reuters) -Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices ...

Amgen is laying off more workers in Ventura County. The bio-pharmaceutical giant said March 16 that it will eliminate about 450 jobs, or less than 2% of its global workforce. That’s on top of 305 cuts ...

March 27 (Reuters) - Amgen Inc's (AMGN.O) battle with Sanofi (SASY.PA) and Regeneron (REGN.O) at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ...

The Supreme Court appeared to struggle Monday over Amgen Inc.'s arguments in a dispute with Sanofi S.A. that two canceled ...

Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a "blatant attempt" to ...

Amgen laid off about 300 employees in January as part of organizational changes. The drugmaker's fourth-quarter revenue fell slightly, as a 4% increase in sales of its own drugs was offset by ...

March 27 (Reuters) - Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent ...